Tempus

IL - ChicagoBiotechnology1 H-1B visas (FY2023)

View 100 open jobs Website LinkedIn Careers Page

Focus: Tempus is an AI-driven drug discovery and medical device company focused on leveraging real-world evidence and molecular profiling across oncology and adjacent therapeutic areas. The company operates from Chicago with 103 active job openings, positioning itself at the intersection of digital health, biotech, and precision medicine.

Oncology Gastroenterology Ophthalmology Neurology

Profile data last refreshed 2h ago · AI intelligence enriched 2w ago

Open Jobs

100-11 this month

Cooling — net -11 jobs in 30d

16 added, 27 removed. Slower than typical.

Should You Work at Tempus?

AI assessment

Tempus offers a compelling role in AI-enabled precision oncology and real-world evidence collection, but suits risk-tolerant professionals comfortable with pre-revenue biotech dynamics and unconventional R&D execution.

Why Work Here

Early-stage pipeline with emerging clinical programs (rebecsinib Phase 1 in Secondary AML, A2B530/A2B694 Phase 1/2 in solid tumors) offers hands-on drug development exposure

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

23 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

xF Tempus assay

Non-Small Cell Lung Cancer (NSCLC)

Growth

Molecular profiling companion diagnostic advancing precision oncology strategy in high-incidence indication.

Zio Patch Monitor

Atrial Fibrillation

Help build intelligence for Tempus

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Heavy hiring in Clinical Operations (46 roles) and Real-World Evidence (11 roles) signals aggressive expansion into data-driven clinical execution

Multi-therapeutic area focus (oncology, cardio, neuro, gastro, ophthalmology) provides diverse career learning opportunities across disease states

Watch Out For

Early pipeline maturity with zero Phase 3 programs and only 2 active Phase 1/2 trials means limited near-term catalysts and long path to regulatory approvals
Private company status with no disclosed financials creates uncertainty around long-term stability, funding runway, and exit timeline
Observational studies dominate the pipeline (11+ programs are data collection/registry efforts), not traditional drug development—career trajectory may diverge from conventional pharma path

Generated by Claude from Tempus's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Wearable device platform extending company footprint into cardiac monitoring and real-world evidence generation.

ECG-based AI Device

Pulmonary Hypertension

Growth

AI-driven diagnostic device targeting rare cardiovascular disease with unmet detection needs.

Pipeline & Clinical Trials

None - Observational Study

Acute Myeloid Leukaemia (AML)

N/A

Clinical Trials (1)

NCT07154823A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

N/A

Umbrella Study for Analysis of Data Related to Patients With Cancer

Cancer

N/A

Clinical Trials (1)

NCT06018753Umbrella Study for Analysis of Data Related to Patients With Cancer

N/A

Automated alert

Aortic Valve Stenosis

N/A

Clinical Trials (1)

NCT06099665Addressing Under-treatment and Health Equity in AS and MR Using an Integrated EHR Platform

N/A

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

Cancer

N/A

Clinical Trials (1)

NCT06207032TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

N/A

Zio Patch Monitor

Atrial Fibrillation

N/A

Clinical Trials (1)

NCT05442203Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease

N/A

Observation

Breast Cancer

N/A

Clinical Trials (1)

NCT06126003Gut and Tumor Microbiome in Patients With Early Stage (II-III), Locally Advanced or Advanced ER-positive and HER2-negative Breast Cancer.

N/A

Observation

Colorectal Cancer

N/A

Clinical Trials (1)

NCT05234177Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

N/A

Observation

Breast Cancer

N/A

Clinical Trials (1)

NCT05179824Tempus Priority Study: A Pan-tumor Observational Study

N/A

Observation

Small Cell Lung Cancer

N/A

Apheresis

Solid Tumor, Adult

N/A

xF Tempus assay

Non Small Cell Lung Cancer (NSCLC)

N/A

Clinical Trials (1)

NCT06997458Liquid BiOpsy, Lung and Colon Cancer in AndaluciA

N/A

Observation

Non-Small Cell Lung Cancer

N/A

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carci

Head and Neck Squamous Cell Carcinoma

N/A

ECG-based AI Device - Results Returned to Investigator

Pulmonary Hypertension

N/A

Clinical Trials (1)

NCT06911632Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

N/A

There are no interventions in this observational study.

Breast Cancer

N/A

Clinical Trials (1)

NCT07211178Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

N/A

Continuous glucose monitoring

Glycemic Response

N/A

Clinical Trials (1)

NCT04881019PRediction Of Glycemic RESponse Study

N/A

rebecsinib

Secondary AML

PHASE_1

Clinical Trials (1)

NCT07250646A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis

Phase 1

A2B694

Solid Tumor, Adult

PHASE_1_2

A2B530

Solid Tumor, Adult

PHASE_1_2

Targeted Therapy Based on Molecular Profiling

Metastatic Malignant Neoplasm

PHASE_2

Clinical Trials (1)

NCT02152254Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II)

Phase 2

Niraparib

Solid Tumor

PHASE_2

Pegylated interferon alpha 2

Hepatitis C

PHASE_4

Clinical Trials (1)

NCT00241618Timing and Duration of Acute Hepatitis C Treatment

Phase 4

Pegylated IFN- alpha 2b

Hepatitis C

PHASE_4

Clinical Trials (1)

NCT00277862Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4

Phase 4

Interview Prep Quick Facts

Portfolio: 16 clinical trials

Top TAs: Oncology, Cardiovascular, Infectious Diseases

H-1B (2023): 1 approval

Open Roles: 100 active jobs

Therapeutic Area Focus

9 pipeline

3 pipeline

2 pipeline

1 pipeline

1 pipeline

Hiring Trend

Stable

100

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Tempus

Should You Work at Tempus?

Why Work Here

Key Products

Watch Out For

Pipeline & Clinical Trials

Open Jobs (100)

Contract Manager

MRD Clinical Account Executive, South Florida

Senior Program Manager, Product Development

Customer Success AI Strategy & Agent Development Lead

Clinical Account Executive, Detroit

MRD Clinical Account Executive, North Florida

Clinical Account Executive, Chicago

Clinical Account Executive, Jacksonville

Clinical Account Executive, South Dallas

Molecular Technologist I/II (High Complexity)

Physical Security Specialist

Molecular Technologist

Sr. BI Engineer

Director, Commercial Connectivity Partnerships

Senior Software Engineer

Director, Business Development - AI Products

Histotechnologist I

Enterprise Solutions Director, Texas

Enterprise Solutions Director, DC/ Virginia

Key Account Director, Data & AI Apps

Clinical Account Executive, Panhandle

Clinical Lab Associate I - Specimen Intake

Senior Software Engineer II, Data Products

Associate Principal Scientist, PharmaR&D

Tradeshow & Event Strategy Manager, Data & Apps (Remote)

Hiring Trend

Visa Sponsorship